药石科技上半年净利7249.81万元，同比下降26.54%

Core Viewpoint - The company reported a revenue of 920 million yuan for the first half of 2025, reflecting a year-on-year growth of 23.48%, while the net profit attributable to shareholders decreased by 26.54% to approximately 72.5 million yuan [1] Financial Performance - Revenue for the first half of 2025 reached 920 million yuan, marking a 23.48% increase compared to the previous year [1] - Net profit attributable to shareholders was approximately 72.5 million yuan, representing a decline of 26.54% year-on-year [1] Strategic Focus - The company aims to maintain a dynamic balance between cost control and strategic development [1] - There is an emphasis on strengthening cost management measures and enhancing operational efficiency [1] - The goal is to gradually restore the gross profit margin to an ideal level to support long-term sustainable development [1]